Browse by Academic Unit (A-Z)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators Name | Item Type
Jump to: A | B | C | D | E | F | H | K | L | P | S | T | W | Z
Number of items at this level: 29.


Allan, J.M., Wild, C.P., Rollinson, S. et al. (7 more authors) (2001) Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapyinduced leukemia. Proceedings of the National Academy of Sciences, 98 (20). pp. 11592-11597. ISSN 0027-8424

Alonso-Camino, V, Rajani, K, Kottke, T et al. (11 more authors) (2014) The Profile of Tumor Antigens Which Can Be Targeted By Immunotherapy Depends Upon the Tumor's Anatomical Site. In: Molecular Therapy. 7th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), 21-24 May 2014, Washington, DC, USA. Nature Publishing Group , S200-S200.

Ashley, L, Jones, H, Forman, D et al. (5 more authors) (2011) Feasibility test of a UK-scalable electronic system for regular collection of patient-reported outcome measures and linkage with clinical cancer registry data: The electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) system. BMC Medical Informatics and Decision Making, 11. 66. ISSN 1472-6947


Brown, SR, Gregory, WM, Twelves, CJ et al. (5 more authors) (2011) Designing phase II trials in cancer: a systematic review and guidance. British Journal of Cancer, 105 (2). 194 - 199 . ISSN 1532-1827

BrĂ¼ning-Richardson, A, Bond, J, Alsiary, R et al. (9 more authors) (2012) NuMA overexpression in epithelial ovarian cancer. PLoS One, 7 (6). ARTN e38945. e38945 - ?. ISSN 1932-6203


Cortes, J, Hudgens, S, Twelves, C et al. (7 more authors) (2015) Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial. Breast cancer research and treatment, 154 (3). 509 - 520. ISSN 0167-6806


Donnelly, O, Vile, R, Pandha, H et al. (2 more authors) (2012) The hitchhiker's guide to virotherapy. Oncotarget, 3 (8). pp. 735-736. ISSN 1949-2553

de Tute, RM, Rawstron, AC, Gregory, WM et al. (9 more authors) (2016) Minimal Residual Disease Following Autologous Stem Cell Transplant In Myeloma: Impact On Outcome Is Independent Of Induction Regimen. Haematologica, 101 (2). e69-e71. ISSN 0390-6078


El-Jawhari, JJ, El-Sherbiny, YM, Scott, GB et al. (8 more authors) (2014) Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes. Molecular Immunology, 58 (2). 160 - 168. ISSN 0161-5890


Feyler, S, Scott, GB, Parrish, C et al. (6 more authors) (2012) Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent. PLoS ONE, 7 (5). e35981. ISSN 1932-6203


Hayes, J, Thygesen, H, Tumilson, C et al. (8 more authors) (2015) Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature. Molecular Oncology, 9 (3). 704 - 714. ISSN 1574-7891

Holmes, TD, Wilson, EB, Black, EVI et al. (5 more authors) (2014) Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT. Proceedings of the National Academy of Sciences of the United States of America (PNAS) , 111 (52). E5688-E5696. ISSN 1091-6490


Kottke, T, Boisgerault, N, Diaz, RM et al. (12 more authors) (2013) Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence. Nature Medicine, 19. 1625 - 1631. ISSN 1078-8956


Langford, K.J., Askham, J.M., Lee, T. et al. (2 more authors) (2006) Examination of actin and microtubule dependent APC localisations in living mammalian cells. BMC Cell Biology, 7 (3). ISSN 1471-2121

Laycock, SD, Hulse, M, Scrase, CD et al. (7 more authors) (2015) Towards the production of radiotherapy treatment shells on 3D printers using data derived from DICOM CT and MRI: preclinical feasibility studies. Journal of Radiotherapy in Practice, 14 (01). 92 - 98. ISSN 1460-3969


Parrish, C, Morris, CTCM, Williams, CD et al. (13 more authors) (2016) Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial. Biology of Blood and Marrow Transplantation, 22 (6). pp. 1009-1016. ISSN 1083-8791

Pawlyn, C, Kaiser, M, Heuck, C et al. (20 more authors) (2016) The spectrum and clinical impact of epigenetic modifier mutations in myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research. ISSN 1078-0432


Schey, S, Brown, SR, Tillotson, A-L et al. (13 more authors) (2015) Bendamustine, thalidomide and dexamethasone combinationtherapy for relapsed/refractory myeloma patients: results ofthe MUKone randomized dose selection trial. British Journal of Haematology, 170 (3). pp. 336-348. ISSN 0007-1048

Seymour, MT (2011) Sequential Chemotherapy for Colorectal Cancer. Lancet Oncology, 12. 1 - 2 (2). ISSN 0140-6736

Sturla, L-M, Merrick, AE and Burchill, SA (2003) FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells. British Journal of Cancer, 89 (7). pp. 1276-1284. ISSN 0007-0920


Taylor, S, Harley, C, Campbell, LJ et al. (6 more authors) (2010) Discussion of emotional and social impact of cancer during outpatient oncology consultations. Psycho-Oncology, 20 (3). 242 - 251 . ISSN 1099-1611

Town, J, Pais, H, Harrison, S et al. (5 more authors) (2016) Exploring the surfaceome of Ewing sarcoma identifies a novel and unique therapeutic target. Proceedings of the National Academy of Sciences, 113 (13).

Twigger, K, Roulstone, V, Kyula, J et al. (14 more authors) (2012) Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer, 12. 368. ISSN 1471-2407


Walker, BA, Boyle, EM, Wardell, CP et al. (24 more authors) (2015) Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma. Journal of Clinical Oncology, 33 (33). pp. 3911-3920. ISSN 0732-183X

Walker, BA, Wardell, CP, Murison, A et al. (18 more authors) (2015) APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nature Communications, 6. ARTN 6997.

Walker, BA, Wardell, CP, Murison, A et al. (18 more authors) (2014) Apobec Family Mutational Signatures Are Associated with Poor Prognosis Translocations in Multiple Myeloma. In: BLOOD. 56th ASH Annual Meeting 2014, 06-09 Dec 2014, San Francisco, California, USA. American Society of Hematology .

Westbury, CB, Freeman, A, Rashid, M et al. (3 more authors) (2014) Changes in mast cell number and stem cell factor expression in human skin after radiotherapy for breast cancer. Radiotherapy and Oncology, 111 (2). 206 - 211. ISSN 0167-8140

Westbury, CB, Haviland, J, Davies, S et al. (7 more authors) (2014) Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy. Radiation Oncology, 9. 103. ISSN 1748-717X


Zougman, A and Banks, RE (2015) C-STrap Sample Preparation Method—In-Situ Cysteinyl Peptide Capture for Bottom-Up Proteomics Analysis in the STrap Format. PLoS ONE, 10 (9). 1 - 7 (7). ISSN 1932-6203

This list was generated on Fri Oct 21 03:37:05 2016 BST.